Skip to main content
SYRE
NASDAQ Life Sciences

Spyre Therapeutics Launches Public Offering to Fund SPY072 Late-Stage Push

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$89.81
Mkt Cap
$8.175B
52W Low
$15.86
52W High
$110.175
52W Position info
466% above low
Off High info
18% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

SYRE has more than doubled off its 52-week low of $15.86.

Summary

Spyre Therapeutics priced its public offering at $85 per share for 4,117,648 shares, raising $350.0 million, with net proceeds earmarked for advancing its pipeline and SPY072 late-stage development. This follows positive Phase 2 data for SPY003 in ulcerative colitis and a strategic shift for SPY072 in rheumatoid arthritis. The capital raise is dilutive to existing shareholders and comes after insider sales under 10b5-1 plans.

Updated with a Reuters report · What changed

Updates

  1. · Reuters — Spyre priced the offering at $85 per share for 4,117,648 shares, raising $350.0 million.

At the time of this announcement, SYRE was trading at $89.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.2B. The 52-week trading range was $15.86 to $110.18. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

SYRE - Latest Insights

SYRE
Nov 03, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $99.73
Real-time Price: $99.11 info
Change: -$0.620 (-0.62%) info
Market Cap: $9.398B info
SYRE
Nov 03, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $99.73
Real-time Price: $99.11 info
Change: -$0.620 (-0.62%) info
Market Cap: $9.398B info
SYRE
Oct 07, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $80.51
Real-time Price: $99.11 info
Change: +$18.60 (+23%) info
Market Cap: $9.398B info
SYRE
Oct 06, 2026, 4:41 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $80.11
Real-time Price: $99.11 info
Change: +$19.00 (+24%) info
Market Cap: $9.398B info
SYRE
Oct 06, 2026, 11:53 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $81.16
Real-time Price: $99.11 info
Change: +$17.95 (+22%) info
Market Cap: $9.398B info